In addition, to explore the anti-tumor pharmacological targets of tadalafil on CRC, we knocked down its canonic target gene pde5 by small interfering RNA (siRNA) and then analyzed the cell viability after different concentrations of tadalafil treatment with or without pde5 knockdown. The gene discussed is PDE5A; the disease is colorectal carcinoma.